Stemcentrx
Develops innovative therapies for cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
$10.2b (Public information from Apr 2016)
South San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$23.5m | Late VC | ||
$42.0m | Series D | ||
$200m | Series F | ||
$250m | Series G | ||
$10.2b Valuation: $10.2b | Acquisition | ||
| Total Funding | $515m | ||
Recent News about Stemcentrx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.